Related by context. All words. (Click for frequent words.) 68 Aileron Therapeutics 65 Stapled Peptide 63 Receptos 63 therapeutic monoclonal antibodies 63 Novosom 62 immunotherapeutics 62 metalloenzymes 62 Adnectin 61 siRNA therapeutics 61 Vaccinex 61 peptide therapeutics 61 Metallophile ™ Technology 60 Anchor Therapeutics 60 bluebird bio 60 biased ligands 60 novel peptide 60 rxRNA 59 Aptamer 59 dAbs 59 polyketide 59 liposomal delivery 59 Inc. Nasdaq ALNY 59 VentiRx 59 Adenosine Therapeutics 58 Locked Nucleic Acid LNA 58 antibody therapeutics 58 rxRNA compounds 58 Avila Therapeutics 58 Agios Pharmaceuticals 58 anticancer therapeutics 58 IAP inhibitors 58 RNA therapeutics 58 therapeutic modality 58 monoclonal antibody therapeutics 58 Anaphore 58 siRNA sequences 58 aptamer therapeutics 58 RNA antagonists 58 AngioChem 58 histone deacetylase inhibitors 58 Zyngenia 58 Ambrx 58 RONDEL ™ 58 microRNA therapeutics 58 molecularly targeted 58 immatics 58 PhaseBio 58 Fleximer R 58 stapled peptides 57 Rib X 57 PROfusion 57 Pepducin 57 TetraLogic Pharmaceuticals 57 biotherapeutics 57 Neuraltus 57 NTDDS 57 Regado 57 proteasome inhibitor 57 commercialize microRNA 57 Nanobody ® 57 TLR Therapeutics 57 epothilones 57 FoldRx Pharmaceuticals Inc. 57 biologic therapeutics 57 miRNA therapeutics 57 sirtuin therapeutics 57 engineered RAP peptides 57 Receptors GPCRs 57 Nautilus Biotech 57 anti mitotic 57 novel anti infective 57 proprietary Biochronomer 57 Phylomer 57 Taligen 57 Nanobody 57 miRagen 57 Celator 57 Galenea 57 histone methyltransferases HMTs 57 Cellzome 57 proteasome inhibitors 57 Antisense 57 Profectus BioSciences 57 Supernus Pharmaceuticals 57 Achaogen 57 Viamet 57 novel antiviral therapeutics 57 monoclonal antibodies 57 therapeutic monoclonal antibody 57 Intellikine 57 aTyr Pharma 57 Cylene 56 Guanilib 56 humanized monoclonal antibodies 56 Alfacell proprietary ribonuclease 56 proprietary LNA 56 siRNA delivery 56 SNALP 56 epigenetic enzymes 56 CB2 selective 56 histone deacetylase HDAC inhibitors 56 Squalamine 56 therapeutics 56 selective androgen receptor modulators 56 Adnectins 56 protein kinase inhibitors 56 Litx 56 PhiloGene 56 Taligen Therapeutics 56 Angiocept 56 RNAi therapeutic targeting 56 aptamers 56 protein therapeutics 56 Syrrx 56 CAMBRIDGE Mass. Alnylam Pharmaceuticals 56 neuronal nicotinic receptors NNRs 56 systemic RNAi 56 NNR Therapeutics 56 vascular disrupting agents 56 Pulmatrix 56 Plexxikon proprietary 56 novel immunotherapeutic 56 Lycera 56 Xanthus Pharmaceuticals Inc. 56 proprietary dermal 56 Locked Nucleic Acid 56 Euroscreen 56 antiviral therapeutics 56 FoldRx 56 BiTE 56 lipid nanoparticle 56 epigenetic therapeutics 56 Regenerative medicine 56 Nasdaq CGEN 56 novel RNAi therapeutics 56 Pepducin technology 56 DNAi 56 Surface Logix 56 Monoclonal antibodies 56 Pancreate 56 Nanobodies 56 Fc fusion protein 56 Dicerna 56 oncolytic 56 antagomirs 55 ProNAi 55 stem cell therapeutics 55 Anticalins 55 siRNA therapeutic 55 TapImmune 55 Pertuzumab 55 novel peptides 55 G Protein Coupled 55 FORMA Therapeutics 55 Phylomer ® 55 Curaxins 55 oligonucleotide therapeutics 55 SR Pharma 55 Syntaxin 55 EyeGate Pharma 55 ddRNAi 55 macrocycles 55 targeted radiotherapeutic 55 anticancer compounds 55 AFFiRiS 55 anticoagulant reversing agent 55 MediVas 55 Helix BioMedix Inc. 55 oncolytic vaccine 55 VisEn Medical 55 tiapamil 55 Vegenics 55 Pentraxin 2 55 tkRNAi technology 55 Aposense Ltd. 55 Nasdaq PANC biotechnology 55 taxane derivative 55 tkRNAi 55 GeneICE 55 anticancer agents 55 theranostics 55 humanized antibody 55 Epizyme 55 Cancer Vaccines 55 Ridaforolimus 55 Phylogica 55 Cathepsin S 55 humanized monoclonal 55 adrenergic regulation 55 Tobira Therapeutics 55 SMARTICLES ® 55 aTyr 55 Protein Kinase C 55 ERYtech Pharma 55 Acetylon 55 Aegis Therapeutics 55 candidate deforolimus 55 oxazolidinone 55 Cyclosert 55 Semafore 55 DOS# 55 Amarantus 55 Heptares 55 ActivX 55 CobaCyte 55 Opsona 55 Afferent 55 MDRNA proprietary 55 HCV protease inhibitors 55 nanopharmaceuticals 55 engineered proteases 55 peptibody 55 Anticalin 55 Aegerion Pharmaceuticals 55 ORTHOCON 55 elbion 55 neuro inflammatory 55 anionic backbone 55 VitiGam 54 histone deacetylase HDAC 54 ProLindac TM 54 nitric oxide donating 54 Sirtris 54 AMPAKINE compounds 54 Mipomersen 54 Aegera 54 Insert Therapeutics 54 drugable targets 54 Proteostasis 54 Inotek Pharmaceuticals Corporation 54 Scil Proteins 54 DiLA2 54 allosteric modulation 54 immunotherapeutic agent 54 JAK kinases 54 transfection reagents 54 cancer immunotherapies 54 integrase inhibitors 54 HSP# inhibitors 54 anticancer therapies 54 PORxin 54 DepoVax TM 54 Dicer Substrate Technology 54 cancer therapeutics 54 Domantis 54 NNRs 54 KL4 Surfactant 54 lipid nanoparticles 54 ribonuclease 54 synergistic combinations 54 ProtoKinetix 54 Atugen 54 Angiochem 54 AtuRNAi 54 NOXXON 54 oncology therapeutics 54 Anticalins R 54 Affinium Pharmaceuticals 54 Mersana 54 Curaxin 54 selective relaxant 54 oral taxane 54 Gemin X 54 small molecule modulators 54 virosome 54 RNA interference RNAi 54 LentiVector 54 iPSC technology 54 Robert L. Bratzler 54 antisense drugs 54 Chimigen 54 HistoRx 54 biocatalysts 54 chimeric monoclonal antibody 54 RECOTHROM R 54 Synageva 54 proprietary polysaccharide 54 multitargeted 54 Quark Biotech Inc. 54 Piramed 54 Small Molecule 54 Innate Pharma 54 isoform selective 54 Fleximer 54 nanomedicines 54 PORxin TM 54 biotherapeutic 54 VaxImmune 54 siRNAs targeting 54 NeurAxon Inc. 54 PI3K inhibitor 54 JAK3 54 proprietary PEGylation 54 theranostic 54 Spiegelmer 54 sd rxRNA 54 KineMed 54 NuMimetic TM 54 Regado Biosciences 54 orphan GPCRs 54 RNA Interference RNAi 54 Conatus Pharmaceuticals 54 Isis antisense 54 renin inhibitors 54 Enkephalin 54 Alnara 54 Scancell 54 Chemokine Receptor 54 Microbia 54 Genstruct 54 receptor modulators 54 Inc. Nasdaq INFI 54 DiaKine 54 cyclophilin inhibitors 54 Affimed 54 Micromet BiTE 54 RNAi therapeutics 54 selective kinase inhibitor 54 Nanobodies ® 54 epothilone 54 LNPs 54 SCYNEXIS 54 melanocortin receptor agonists 54 proprietary phage display 54 HSP# inhibitor 54 peptidomimetic 54 SynCon TM 54 CompoZr 54 ACTCellerate 54 Ustekinumab 54 Locus Pharmaceuticals 54 GENFIT 54 Sangamo ZFP technology 54 anti infective treatments 53 ProtAffin 53 TARIS Biomedical 53 catalytic antioxidant compounds 53 CEQ# 53 chemical entities NCEs 53 DsiRNA 53 XmAb 53 RNAi therapeutic 53 protein receptors lectins 53 Metaphore 53 Addrenex 53 GlycArt 53 Spiegelmers R 53 SARMs 53 Virdante 53 Delenex 53 exon skipping 53 PNT# 53 TransMolecular 53 selective inhibition 53 PolyTherics 53 targeting CD# 53 acetylcholinesterase AChE 53 novel immunomodulatory 53 targeted antifolate 53 monoclonal antibody mAb 53 ALN PCS 53 Nanobodies R 53 recombinant antibody 53 immunotherapeutic 53 Capsulution 53 antisense therapeutics 53 Spherics 53 Dr. Aiping Young 53 small molecule tyrosine 53 Spiegelmers ® 53 ERYtech 53 AMPK activators 53 EndoTAG TM 53 Liposomal 53 Bassil Dahiyat Ph.D. 53 ETBs 53 small molecule inhibitors 53 photodynamic 53 tubulin inhibitors 53 InNexus 53 nanocarriers 53 vinca alkaloid 53 RNAi 53 RayBiotech 53 Bavarian Nordic patented 53 Olaparib 53 ESBATech AG 53 Systemic Delivery 53 small molecule 53 PDE4 inhibitor 53 Avidex 53 Cara Therapeutics 53 Neogenix 53 biobetter 53 immuno oncology 53 Pervasis 53 TLR9 agonists 53 EHT AGN 53 VASTox 53 Acuity Pharmaceuticals 53 HepDirect R 53 Lipocine 53 Mithridion 53 PERCIVIA 53 outlicensing 53 recombinant polyclonal antibodies 53 ATL# [002] 53 Akebia Therapeutics 53 Tarvacin TM 53 Raven Biotechnologies 53 peptide mimetics 53 Hsp# inhibition 53 biopharmaceuticals 53 tranilast 53 botanical therapeutics 53 Archemix Corp. 53 Promedior 53 Enhanze 53 antisense oligonucleotides 53 human antibody therapeutics 53 Tranzyme 53 platinum chemotherapeutic 53 histone deacetylase 53 Regulus Therapeutics 53 telomerase inhibitor 53 GlycoVaxyn 53 Immunotherapeutic 53 biologic therapies 53 Alligator Bioscience 53 protein kinase inhibitor 53 NanoString 53 ATL# [001] 53 recombinant antibodies 53 ProFibrix 53 Kolltan Pharmaceuticals 53 HuCAL antibody 53 Marillion Pharmaceuticals 53 Galenea Corp. 53 iCeutica 53 Sphingomab 53 Nanobiotix 53 kinase inhibitors 53 SGLT inhibitors 53 Liprotamase 53 BioLeap 53 OXIGON TM 53 treat gastrointestinal disorders 53 adrenal steroid hormones 53 Nasdaq ENZN 53 deacetylase inhibitors 53 Myolimus 53 topically delivered 53 oral antiviral 53 antibody fragment therapeutics 53 Homspera TM 53 MEK inhibitors 53 siRNA compounds 53 Relypsa 53 Chiral Quest 53 PARP inhibitors 53 CB1 antagonists 53 ZFN technology 53 novel therapeutic antibodies 53 Paramount BioSciences 53 Davanat 53 therapeutic antibodies 53 Aquinox 53 siRNA binds 53 rxRNA TM compounds 53 Trophos 53 Ostabolin C TM 53 Monoclonal antibody 53 Santaris Pharma 53 anti CD# monoclonal 52 CureDM 52 OncoVEX 52 NDDS 52 glycomics 52 TOPIGEN 52 Forma Therapeutics 52 Elesclomol 52 biased ligand 52 selective orally bioavailable 52 preclinical compounds 52 bioinnovation 52 novel anticancer 52 Epeius Biotechnologies Corporation 52 Aganocide 52 OncoMed 52 therapeutic mAbs 52 ophthalmic therapeutics 52 Endotis 52 NEUGENE R 52 PharmaDirections 52 Conforma 52 NexACT R 52 OGeS 52 GPCR targets 52 immunotoxin 52 ALN HTT 52 SMIP 52 NEUGENE 52 OTCBB HXBM developer 52 enGene 52 Seaside Therapeutics 52 Salmedix 52 SMARTICLES 52 Nasdaq PARD biopharmaceutical 52 IIB ActRIIB 52 Lipoxen 52 Affibody 52 Scynexis 52 Cyclosert TM 52 aptamer 52 Annexin A5 52 Vernalis plc 52 optical biosensors 52 DNA oligonucleotides 52 NexGenix 52 glycobiology 52 LifeGen 52 Astex 52 antitumoral 52 Aduro BioTech 52 maturation inhibitors 52 Santaris 52 Scaffold Based 52 antineoplastic agents 52 oncolytic viruses 52 ASONEP TM 52 SIMPLE Antibody TM 52 lentiviral vectors 52 Syndax 52 Anticalins ® 52 Bioral 52 pegylation 52 RNA antagonist 52 renin inhibitor 52 phage display 52 vascular disrupting agent 52 NeoLipid TM 52 Epothilones 52 Sphingomab TM 52 Mersana Therapeutics 52 vaccinology 52 Stemgent 52 Photodynamic therapy PDT 52 LNA TM 52 Corixa Corporation 52 Ampakine compounds 52 Affibody ® molecules 52 multi kinase inhibitor 52 ESBATech 52 LNP formulations 52 proprietary Anticalin 52 Merrimack Pharmaceuticals 52 Zenyaku Kogyo 52 PRNewswire FirstCall Neurogen 52 HepDirect 52 cellular reprogramming 52 small molecule PEGylation 52 Maxy G# 52 immunotherapy treatments 52 phage display technology 52 patented Bioral 52 polyclonal antibody 52 GIPET 52 PEGylation 52 Adherex Technologies 52 Biolipox 52 combinatorial chemistry 52 Syntonix 52 antisense 52 Velcura 52 allogeneic cell 52 Molecular Profiling 52 Adnexus Therapeutics 52 inhibit KSP 52 Carigent 52 stable nucleic acid 52 PEGylated 52 SoluBest 52 Portola Pharmaceuticals 52 InNexus Biotechnology 52 Nektar PEGylation technology 52 preclinically 52 polyketides 52 Affimed Therapeutics AG 52 Onconase 52 Kleanthis G. Xanthopoulos Ph.D. 52 KemPharm 52 AV HALT 52 selective immunoproteasome inhibitor 52 BioMachines 52 CytomX Therapeutics 52 Prime BioResearch 52 Optimata 52 Neotropix 52 POTELLIGENT ® 52 AVI NEUGENE 52 PsychoGenics 52 Cogane 52 Pervasis Therapeutics Inc. 52 regenerative therapeutics 52 molecular imaging radiopharmaceutical 52 Tesetaxel 52 transcutaneous immunization TCI 52 Astex Therapeutics 52 UltiMAb 52 Catalyst Biosciences 52 kinase profiling 52 metabolite identification 52 selective kinase inhibitors 52 siRNA Delivery 52 Targeted Chemotherapy 52 VEGF receptor 52 A3 adenosine receptor 52 Archexin 52 bispecific antibody 52 Chemetics R 52 Tumour Vascular Disrupting Agent 52 Venkat Jasti CEO 52 Etubics 52 novel therapeutics 52 Dyax phage display 52 Targeted Immunotherapy 52 Ataluren 52 anti CD# antibody 52 BCR ABL inhibitors 52 VR1 52 High Impact AMPAKINE 52 Anavex #-# 52 drug conjugates ADCs 52 HDAC inhibition 52 antisense drug 52 Cambria Biosciences 52 XL# XL# 52 Hybridon 52 Phytomedics 52 NASDAQ AVII developer 52 ghrelin antagonist 51 Protein Therapeutics 51 romazarit 51 Panzem 51 novel immunotherapies 51 DNA plasmids 51 photodisinfection 51 Phage Pharmaceuticals 51 SGLT Inhibitors 51 Anti Infectives 51 Tranzyme Pharma 51 NNR Therapeutics TM 51 Afferent Pharmaceuticals 51 NovaBay Aganocide compounds 51 fusion inhibitors 51 OvaRex R 51 OTCBB PYTO FWB ET6 51 2DG 51 UniBody 51 herpes simplex viruses 51 peptide conjugated 51 Anidulafungin 51 Symadex 51 Biotherapeutics 51 Factor NGF 51 gamma secretase inhibitors 51 DPX Survivac 51 XmAb ™ 51 FluoroPharma 51 HepaLife 51 Novasome 51 Kinases 51 SuperAntibody 51 metaglidasen 51 Symphogen 51 ALN TTR 51 oncolytic virus 51 clinically validated targets 51 Ore Pharmaceuticals 51 Aviptadil 51 NASDAQ ABII 51 Resolvyx 51 GENova 51 drug conjugate 51 GelSite R polymer 51 pan HDAC inhibitor 51 Howard H. Pien 51 Revance 51 Curidium 51 Inc. Nasdaq IMGN 51 NanoCrystal 51 Pichia pastoris 51 anti secretory 51 Factor VIIa 51 MAXY VII 51 antisense inhibitor 51 Cabilly patent 51 Therapeutic antibodies 51 Revimmune TM 51 selective HDAC inhibitors 51 NS4B 51 synthetic siRNAs 51 Peptide 51 proven DuraSite ® 51 Chemokine 51 Xenon Pharmaceuticals 51 MCU cardiovascular 51 immunomodulator 51 ZFP TF 51 Odyssey Thera 51 Viacell 51 MAbs 51 NovImmune 51 TÎ ² 4 51 Diatos 51 dSLIM 51 Nasdaq ALNY 51 Lightlake Therapeutics 51 Alantos 51 VDAs 51 polymerase inhibitors 51 OPi 51 covering SNALP 51 mAbs 51 defensin mimetic antibiotic 51 Ercole Biotech 51 Genospectra 51 radezolid 51 Supernus 51 antibody fragment 51 Nasdaq IDRA 51 CARBOSOME TM formation 51 Creabilis Therapeutics 51 targeting PCSK9 51 RONDEL TM 51 Induced pluripotent stem cells 51 Spirogen 51 TLR agonists 51 Sloning 51 integrin receptors 51 humanized antibodies 51 Elixir Pharmaceuticals 51 Cannasat 51 synthetic peptides 51 Selecta Biosciences Inc. 51 JAK inhibitors 51 IgG1 antibody 51 therapeutic peptides 51 Sapacitabine 51 Dicer Substrate 51 myelofibrosis polycythemia vera 51 ArQule Kinase Inhibitor Platform 51 fusion proteins 51 MVA BN R 51 Controlled Delivery 51 synthetic genomics 51 Decision Biomarkers 51 PSMA antibody 51 Quark Biotech 51 Diasome 51 OMP #M# 51 CyDex Pharmaceuticals 51 Gamma secretase 51 Epiphany Biosciences 51 Inc. NASDAQ CRIS 51 delivered RNAi therapeutic 51 genomic proteomic 51 generation antisense 51 recombinant adeno associated 51 prostone 51 vivo validation 51 LentiVector technology 51 proprietary Dicer Substrate Technology 51 Tarvacin 51 Kiadis 51 Dynogen 51 ophthalmology dermatology cardiovascular disease 51 inhibit metastasis 51 plasmid DNA pDNA 51 diagnostic biomarkers 51 Neurobiological Technologies 51 NYSE Amex AEN 51 Nitec 51 polymer conjugate technology 51 microtubule inhibitor 51 RNAi molecules 51 MMAE 51 CBLC# 51 AEMD 51 HIV integrase inhibitors 51 ZFP technology 51 OncoMed Pharmaceuticals 51 Cellerant 51 humanised monoclonal antibody 51 orally bioavailable 51 SYGNIS 51 antiviral compounds 51 protein mTOR 51 delipidation 51 Vaxart 51 Daclizumab 51 Intravail ® 51 TRAIL receptor antibodies 51 P#X# 51 bioabsorbable polymer 51 Liquidia 51 HTS assay 51 anti phosphatidylserine 51 Prima BioMed 51 AN# novel 51 peptides proteins 51 Stem Cell Innovations 51 Genedata Phylosopher ® 51 Calixa 51 Catabasis 51 IAP inhibitor 51 BioSilicon TM 51 adenoviral vectors 51 ANTISENILIN R 51 Viprovex TM 51 Oligonucleotide 51 mda 7 51 JAK2 kinase 51 Alnylam #x# 51 PROT biotechnology 51 Alnylam RNAi 51 NASDAQ PANC biotechnology 51 clinically differentiated 51 THR beta agonist 51 IMiDs R 51 proteins peptides 51 Psynova 51 SCIB1 51 Cempra 51 covalent drugs 51 Accuri C6 51 MTP inhibitor 51 Idera Pharmaceuticals 51 immuno modulatory 51 CDP# 51 p# inhibitor 51 selectively inhibit 51 situ gelling 51 Urokinase 51 TG# [003] 51 reverse vaccinology 51 tubulin inhibitor 51 DsiRNA molecules 51 Sanochemia 51 Akesis Pharmaceuticals 51 TLR9 agonist 51 anti CD# antibodies 51 penetrating peptides 51 lentiviral vector 51 GPCR 51 Mirus Bio 51 Quotient Bioresearch 51 Aganocide TM 50 bispecific 50 OTCQB ABPI 50 JAK2 inhibitor 50 investigational humanized monoclonal antibody 50 Amunix 50 ImmunGene 50 GlycosBio 50 biotherapy 50 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 50 Nucleonics 50 functional genomics 50 Potelligent 50 anticancer agent 50 TheraGenetics 50 CyDex 50 Alligator Bioscience AB 50 Theranostics 50 Lixivaptan 50 chimeric antibodies 50 bacterial enzyme 50 antisense oligonucleotide 50 OTCBB PYTO 50 POTELLIGENT R 50 KAI Pharmaceuticals 50 Prolexys 50 ChemoCentryx 50 EyeGate 50 RNAi Therapeutics 50 purinergic receptors P#X# 50 LEX System 50 Allozyne 50 Gelesis 50 allosteric modulator 50 Chronogen 50 lipidomics 50 small molecule thrombopoietin 50 commercializing anti infective 50 RNA interference RNAi therapeutics 50 Nasdaq RXII 50 immunomodulators 50 druggable targets 50 molecularly targeted therapy 50 Alnylam Pharmaceuticals Nasdaq ALNY 50 lipid particles SNALP 50 platensimycin 50 HepeX B 50 SGLT2 inhibitors 50 BioVex 50 Ophthotech 50 generation NEUGENE antisense 50 monoclonal antibodies MAbs 50 Argolyn 50 auristatin 50 orally administered pharmacological chaperones 50 Cerenis 50 Suven 50 Tarvacin Anti Viral 50 AVAX Technologies Inc. 50 HCV polymerase 50 Abiraterone 50 biomarker assays 50 prodrugs 50 oxidative stress inducer 50 botulinum neurotoxin 50 KinomeScan 50 ARRY # 50 therapeutic radiopharmaceuticals 50 GlycoMimetics 50 kinase inhibitor 50 OTCBB PWRM.OB 50 Transfection Reagent 50 product platforms AZX# 50 Aegera Therapeutics 50 antisense inhibitors 50 Intradigm Corporation 50 Juvaris 50 NanoTab 50 Daniel Junius 50 immune modulating 50 proprietary biomaterials 50 Quark Pharmaceuticals 50 Romidepsin 50 HCV protease 50 Talabostat 50 Graffinity 50 Myocet 50 Makefield Therapeutics 50 diagnostic molecular imaging 50 Soliris eculizumab 50 peptidic 50 AvalonRx R 50 Neurogen Corporation 50 Maribavir 50 Qdot 50 DiLA2 Platform 50 lipidoid 50 platform HDL Mimetic 50 rxRNA ™ compounds 50 HCV protease inhibitor 50 EZN 50 Duncan Higgons 50 cardio renal 50 mitotic kinesins 50 AtuPLEX 50 nicotinic alpha 7 50 oxidative stress induction 50 PDE# inhibitors 50 PowderMed 50 Selcia 50 H3 Biomedicine 50 pRNA 50 liposomal formulation 50 biomedicines 50 Synthetic biology 50 ARYx Therapeutics 50 PLX# 50 echinocandin 50 peptide fragments 50 BioFocus DPI Galapagos 50 BioPharma 50 Biothera 50 Listeria vaccine 50 JAK1 50 Ceregene 50 virus AAV 50 COX Inhibiting Nitric Oxide 50 NASDAQ BTRX pharmaceutical 50 CXCR4 receptor 50 BioSilicon 50 iPierian 50 Ensysce 50 HepDirect prodrug 50 CCR9 antagonist 50 SOLVAY PHARMACEUTICALS 50 AKIP 50 OTCBB NVLT biopharmaceutical 50 TRC# 50 synthetic siRNA 50 NASDAQ EPIX 50 Repligen Corporation 50 Oramed